News & Publications

Ai2 and Providence Swedish Cancer Institute partnership visual

Ai2 and Providence Swedish Cancer Institute Partner to Advance AI-Assisted Scientific Discovery

The collaboration includes clinically meaningful research findings on lobular breast cancer, and a local deployment to enable next-gen discovery while keeping clinical data secure.

Phase I Trials Deliver Breakthrough Survival Gains in Small Cell Lung Cancer

Results from the DeLLphi-303 trial show one of the most meaningful survival improvements ever reported in extensive-stage small cell lung cancer

Next-Generation Science Panel

Discovering the Future of Cancer Research — Tonight's Visionaries, Tomorrow's Breakthroughs

Inside the Paul G. Allen Research Center

A window into the programs and scientific vision that shape our work

High-Sensitivity ctDNA Assay Helps Map Metastatic Breast Cancer

Capturing early shifts that influence disease course

Identifying molecular clues that may explain how certain early breast cancers become invasive.

Tracking the Evolution of Atypical Ductal Hyperplasia